Rigaku to acquire Agilent’s XRD business

Skip to Navigation


  • Published: Apr 7, 2015
  • Author: Jon Evans
  • Source: Agilent Technologies
  • Suppliers: Agilent Technologies
  • Channels: X-ray Spectrometry

Agilent Technologies has agreed to sells its X-ray diffraction (XRD) business to Rigaku, a Japanese scientific instrumentation company.

Acquired as part of Agilent’s purchase of Varian in 2010, the XRD group is a key manufacturer of single-crystal X-ray instruments for the global chemical crystallography market. Rigaku plans to combine XRD with its existing crystallography business to form a new business unit. XRD products will continue to be developed and produced at existing factories in Poland and Japan.

‘The acquisition of Agilent’s X-ray crystallography business represents a significant step in the expansion of our single-crystal X-ray business,’ said Hikaru Shimura, Rigaku president and CEO. ‘By combining Agilent’s XRD business with Rigaku’s expertise in protein crystallography, we will be able to leverage the best technologies from both groups to provide our current and future customers with world-class solutions for single-crystal analysis.’

‘This agreement is a positive development for the XRD business,’ said Patrick Kaltenbach, president, Agilent life sciences and applied markets group. ‘I am confident that Rigaku will provide excellent support to grow the XRD business with complementary technology and the expertise of a highly talented team.’

Social Links

Share This Links

Bookmark and Share


Suppliers Selection
Societies Selection

Banner Ad

Click here to see
all job opportunities

Most Viewed

Copyright Information

Interested in spectroscopy? Visit our sister site spectroscopyNOW.com

Copyright © 2018 John Wiley & Sons, Inc. All Rights Reserved